Insider Trades44 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 6,115 | $23.50 | $1.0B | -7.34% | +36.22% | $143.7K | -8.94% | — | — |
| Jun 3, 2026 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 3,187 | $22.32 | $1.0B | -7.34% | +36.22% | $71.1K | -4.45% | — | — |
| Jun 3, 2026 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 4,728 | $22.32 | $1.0B | -7.34% | +36.22% | $105.5K | -2.11% | — | — |
| Jun 3, 2026 | Sell | PCRX | Kristen Williams | Chief Administrative Officer | 18,787 | $22.29 | $1.0B | -7.34% | +36.22% | $418.8K | -5.17% | — | — |
| Apr 23, 2026 | Sell | PCRX | Shawn Cross | Chief Financial Officer | 25,882 | $20.80 | $1.0B | -7.34% | +36.22% | $538.5K | +0.00% | — | — |
| Apr 20, 2026 | Sell | PCRX | Shawn Cross | Chief Financial Officer | 24,118 | $20.77 | $1.0B | -7.34% | +36.22% | $501.0K | +0.00% | — | — |
| Mar 17, 2026 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 3,261 | $22.82 | $1.0B | -7.34% | +36.22% | $74.4K | -1.44% | — | — |
| Jan 30, 2026 | Sell | PCRX | Brendan Teehan | Chief Commercial Officer | 5,182 | $20.54 | $1.0B | -7.34% | +36.22% | $106.4K | -9.53% | — | — |
| Jan 30, 2026 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 6,168 | $20.54 | $1.0B | -7.34% | +36.22% | $126.7K | -3.46% | — | — |
| Jan 30, 2026 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 6,751 | $20.70 | $1.0B | -7.34% | +36.22% | $139.7K | -5.85% | — | — |
| Jan 30, 2026 | Sell | PCRX | Kristen Williams | Chief Administrative Officer | 30,271 | $20.54 | $1.0B | -7.34% | +36.22% | $621.6K | -9.89% | — | — |
| Jan 30, 2026 | Sell | PCRX | Frank D. Lee | Chief Executive Officer | 41,488 | $20.54 | $1.0B | -7.34% | +36.22% | $852.2K | -9.42% | — | — |
| Jan 2, 2026 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 381 | $24.46 | $1.0B | -7.34% | +36.22% | $9.3K | -0.21% | — | — |
| Jan 2, 2026 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 1,575 | $24.26 | $1.0B | -7.34% | +36.22% | $38.2K | -1.30% | — | — |
| Jan 2, 2026 | Sell | PCRX | Frank D. Lee | Chief Executive Officer | 9,272 | $24.46 | $1.0B | -7.34% | +36.22% | $226.8K | -2.06% | — | — |
| Dec 31, 2025 | Buy | PCRX | Brendan Teehan | Chief Commercial Officer | 402.268 | $10.76 | $1.0B | -7.34% | +36.22% | $4.3K | +0.74% | — | — |
| Dec 9, 2025 | Sell | PCRX | Shawn Cross | Chief Financial Officer | 50,000 | $20.76 | $1.0B | -7.34% | +36.22% | $1.0M | +0.00% | — | — |
| Nov 17, 2025 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 3,960 | $24.09 | $1.0B | -7.34% | +36.22% | $95.4K | -2.17% | — | — |
| Nov 10, 2025 | Sell | PCRX | Shawn Cross | Chief Financial Officer | 12,060 | $22.09 | $1.0B | -7.34% | +36.22% | $266.4K | -17.65% | — | — |
| Oct 31, 2025 | Sell | PCRX | Shawn Cross | Chief Financial Officer | 6,690 | $21.38 | $1.0B | -7.34% | +36.22% | $143.0K | -8.92% | — | — |
| Aug 1, 2025 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 315 | $22.07 | $1.0B | -7.34% | +36.22% | $7.0K | -0.17% | — | — |
| Jun 3, 2025 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 5,084 | $26.40 | $1.0B | -7.34% | +36.22% | $134.2K | -2.72% | — | — |
| Jun 3, 2025 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 8,952.335 | $26.28 | $1.0B | -7.34% | +36.22% | $235.3K | -6.70% | — | — |
| Jun 3, 2025 | Sell | PCRX | Kristen Williams | Chief Administrative Officer | 20,538 | $26.29 | $1.0B | -7.34% | +36.22% | $539.9K | -5.74% | — | — |
| Jan 2, 2025 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 159 | $18.33 | $1.0B | -7.34% | +36.22% | $2.9K | -0.42% | — | — |
| Jan 2, 2025 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 1,250 | $18.38 | $1.0B | -7.34% | +36.22% | $23.0K | -0.66% | 10b5-1 | — |
| Jan 2, 2025 | Sell | PCRX | Frank D. Lee | Chief Executive Officer | 9,375 | $18.33 | $1.0B | -7.34% | +36.22% | $171.8K | -8.70% | — | — |
| Dec 31, 2024 | Buy | PCRX | Daryl Gaugler | Chief Operating Officer | 243.537 | $16.01 | $1.0B | -7.34% | +36.22% | $3.9K | +0.21% | — | — |
| Dec 13, 2024 | Sell | PCRX | Daryl Gaugler | Chief Operating Officer | 500 | $19.76 | $1.0B | -7.34% | +36.22% | $9.9K | -0.43% | 10b5-1 | — |
| Sep 13, 2024 | Sell | PCRX | Daryl Gaugler | Chief Operating Officer | 500 | $12.86 | $1.0B | -7.34% | +36.22% | $6.4K | -0.43% | 10b5-1 | — |
| Aug 12, 2024 | Buy | PCRX | Frank D. Lee | Chief Executive Officer | 8,264 | $12.10 | $1.0B | -7.34% | +36.22% | $100.0K | +8.30% | — | — |
| Aug 1, 2024 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 1,250 | $20.22 | $1.0B | -7.34% | +36.22% | $25.3K | -0.66% | 10b5-1 | — |
| Jun 28, 2024 | Buy | PCRX | Daryl Gaugler | Chief Operating Officer | 160.368 | $24.32 | $1.0B | -7.34% | +36.22% | $3.9K | +0.14% | — | — |
| Jun 28, 2024 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 4,187.271 | $27.89 | $1.0B | -7.34% | +36.22% | $116.8K | -1.12% | 10b5-1 | — |
| Jun 13, 2024 | Sell | PCRX | Daryl Gaugler | Chief Operating Officer | 1,000 | $28.38 | $1.0B | -7.34% | +36.22% | $28.4K | -0.85% | 10b5-1 | — |
| Jun 13, 2024 | Sell | PCRX | Kristen Williams | Chief Administrative Officer | 7,452 | $28.38 | $1.0B | -7.34% | +36.22% | $211.5K | -6.75% | 10b5-1 | — |
| Jun 12, 2024 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 3,970 | $28.72 | $1.0B | -7.34% | +36.22% | $114.0K | -9.44% | 10b5-1 | — |
| Jun 11, 2024 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 5,012 | $28.57 | $1.0B | -7.34% | +36.22% | $143.2K | -10.11% | — | — |
| Jun 3, 2024 | Sell | PCRX | Jonathan Slonin | Chief Medical Officer | 1,615 | $30.89 | $1.0B | -7.34% | +36.22% | $49.9K | -3.15% | — | — |
| Jun 3, 2024 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 1,843 | $30.89 | $1.0B | -7.34% | +36.22% | $56.9K | -8.18% | — | — |
| Jun 3, 2024 | Sell | PCRX | Daryl Gaugler | Chief Operating Officer | 2,754 | $30.89 | $1.0B | -7.34% | +36.22% | $85.1K | -4.20% | — | — |
| Jun 3, 2024 | Sell | PCRX | Charles A. Iii Reinhart | Chief Financial Officer | 2,979 | $30.89 | $1.0B | -7.34% | +36.22% | $92.0K | -6.99% | — | — |
| Jun 3, 2024 | Sell | PCRX | Kristen Williams | Chief Administrative Officer | 3,011 | $30.89 | $1.0B | -7.34% | +36.22% | $93.0K | -5.10% | — | — |
| Jan 2, 2024 | Sell | PCRX | Lauren Riker | Senior Vice President, Finance | 159 | $32.00 | $1.0B | -7.34% | +36.22% | $5.1K | -0.70% | — | — |